US Edition
News from psychiatrictimes.com
We’ve assigned a rating of High factuality to psychiatrictimes.com. You can read more about how we’ve determined psychiatrictimes.com’s credibility and reliability as a news source here: https://ground.news/rating-system.
Information about psychiatrictimes.com
Where is psychiatrictimes.com located?psychiatrictimes.com's WebsiteMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top psychiatrictimes.com News
Alzheimer's DiseaseBristol Myers Squibb & Co. (NYSE:BMY) on Wednesday said it would enroll additional patients in the ADEPT-2 Phase 3 study.
BMY shares are climbing with conviction. See the market dynamics here. The ADEPT-2 study is a multicenter, randomized, double-blind, placebo-controlled trial assessing the safety and efficacy of Cobenfy in subjects with psychosis associated with Alzheimer’s disease dementia. The study is designed to evaluate the primary endp…See the Story
Bristol Myers Pushes Data Readout For Key Alzheimer's Psychosis Study After Irregularities - Bristol-Myers Squibb (NYSE:BMY)
75% Center coverage: 4 sources
